View in EDS

Development of Antibody and Antibody Fragment-Based Radiopharmaceuticals for Cancer Imaging and Therapy.

Saved in:
Bibliographic Details
Title: Development of Antibody and Antibody Fragment-Based Radiopharmaceuticals for Cancer Imaging and Therapy.
Authors: Kang CS; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul, 01812 Republic of Korea.
Source: Nuclear medicine and molecular imaging [Nucl Med Mol Imaging] 2026 Jun; Vol. 60 (3), pp. 166-184. Date of Electronic Publication: 2025 Dec 02.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 101530478 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1869-3474 (Print) Linking ISSN: 18693474 NLM ISO Abbreviation: Nucl Med Mol Imaging Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42273652
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of Antibody and Antibody Fragment-Based Radiopharmaceuticals for Cancer Imaging and Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kang+CS%22">Kang CS</searchLink>; Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul, 01812 Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101530478%22">Nuclear medicine and molecular imaging</searchLink> [Nucl Med Mol Imaging] 2026 Jun; Vol. 60 (3), pp. 166-184. <i>Date of Electronic Publication: </i>2025 Dec 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101530478 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1869-3474 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218693474%22">18693474 </searchLink><i>NLM ISO Abbreviation: </i>Nucl Med Mol Imaging <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42273652
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s13139-025-00969-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 166
    Titles:
      – TitleFull: Development of Antibody and Antibody Fragment-Based Radiopharmaceuticals for Cancer Imaging and Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kang CS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1869-3474
          Numbering:
            – Type: volume
              Value: 60
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Nuclear medicine and molecular imaging
              Type: main
ResultId 1